News
Dexcom ONE real-time Continuous Glucose Monitoring (rt-CGM) System available on prescription in the UK, improving access to rt-CGM for people with diabetes
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, and NHS England today announced the availability of the easy to use Dexcom ONE
Humana ranked No. 1 among health insurers for Customer Experience
For two years in a row, Humana ranked No. 1 among health insurers for customer experience (CX) quality in Forrester’s proprietary 2022 U.S. Customer Experience Benchmark survey. The ranking was
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
MD Medical Group Investments Plc: MD Medical Group announces operating results for Q2 2022
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
DGAP-News: MediClin AG: Consolidated sales for the first half of 2022 up 10% on the previous pandemic figure – no change in forecast
Dexcom Reports Second Quarter 2022 Financial Results
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2022.
Second Quarter 2022 Financial Highlights:
-
Revenue grew 17% versus the same
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Chemed Reports Second-Quarter 2022 Results
Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest
Acadia Healthcare Reports Second Quarter 2022 Results and Raises 2022 Guidance
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the second quarter ended June 30, 2022.
Second Quarter Highlights
-
Revenue totaled $651.7 million, an
Agilent 2022 Early Career Professor Award Presented to Stefanos Nikolaidis
Agilent Technologies Inc. (NYSE: A) announced today that Stefanos Nikolaidis Ph.D. has received the Agilent 2022 Early Career Professor Award. Dr. Stefanos Nikolaidis is an Assistant Professor of
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
DGAP-Adhoc: Eckert & Ziegler: Strong Growth in Revenues and Earnings in 2nd Quarter
Simulations Plus Presented New Scientific Developments at PAGE 2022
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the presentation of five scientific
Agilent ESG Report Highlights Plans and Progress to Ensure Future Sustainable Growth
Agilent Technologies Inc. (NYSE: A) today released its inaugural Environmental, Social, and Governance (ESG) report, including the company’s first TCFD climate risk report; details on its
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit International Organization for Childhood Cancer
Simulations Plus (Nasdaq: SLP) is celebrating 25 years in business and continuing the commitment to improve public health through innovative solutions with a $25,000 donation to St. Jude Children’s
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
DGAP-News: Eckert & Ziegler Affiliate Receives Further NIAID Funding for Clinical Development
Sartorius Stedim Biotech SA: Information on Document Availability
Humana Hiring 300 Seasonal Remote Positions
Leading health and well-being company Humana Inc. (NYSE: HUM) announced it is looking to hire about 300 seasonal Enrollment Representatives for nationwide work-from-home positions.
Humana’s
STAAR Surgical to Report Second Quarter Results on August 10, 2022
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
DGAP-News: Eckert & Ziegler and PRECIRIX Sign Agreement on Priority Supply of the Therapeutic Radioisotope Actinium-225 (Ac-225)
Agilent’s Certified Pre-Owned Instruments Program Receives Environmental Award
Agilent Technologies Inc. (NYSE: A) today announced the company’s Certified Pre-Owned Instruments Program received a Top Project award for achieving outstanding results in reducing waste. The award
Agilent to Announce Third-Quarter Fiscal Year 2022 Financial Results August 16
Agilent Technologies Inc. (NYSE: A) today announced it will release financial results for the third quarter of fiscal year 2022 after the stock market closes on Tuesday, Aug. 16. The company will